Browse > Article

Studies on the Binding Affinity of Aminoglycoside Antibiotics to the HIV-l Rev Responsive Element for Designing Potential Antiviral Agents  

Kwon, Young-Joo (College of Pharmacy, Ewha Womans University)
Publication Information
Journal of Microbiology and Biotechnology / v.16, no.1, 2006 , pp. 109-117 More about this Journal
Abstract
The Rev binding to Rev Responsive Element (RRE) of HIV-1 mRNA plays an important role in the HIV-I viral replication cycle. The disruption of the Rev-RRE interaction has been studied extensively in order to develop a potential antiviral drug. In order to provide the basis for a more promising approach to develop a Rev-RRE binding inhibitor against HIV-I infection, it is necessary to understand the binding modes of the aminoglycoside antibiotics to RRE. In the present study, the binding mode of a modified antibiotic, a neamine conjugated with pyrene and arginine (NCPA), to RRE has been studied by the methods of $T_m$ measurement and spectroscopic analysis of RRE with or without antibiotics. The results confirmed that NCPA competes with Rev in binding to RRE.
Keywords
Aminoglycoside antibiotics; HIV-1 RRE; binding affinity to RRE; inhibition of HIV-1 Rev-RRE interaction;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 3  (Related Records In Web of Science)
연도 인용수 순위
1 Emerman, M., R. Vazeux, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope specific RNA localization. Cell 57: 1155-1165   DOI   ScienceOn
2 Icacmpo, S. and A. Cochrane. 1996. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J. Virol. 70: 8332-8339
3 Ippolito, J. A. and T. A. Steitz. 2000. The structure of the HIV-1 RRE high affinity Rev binding site at 1.6 ${\AA}$ resolution. J. Mol. Biol. 295: 711-717   DOI   ScienceOn
4 Kharel, M., B. Subba, H. C. Lee, K. Liou, J. S. Woo, D. H. Kim, Y.-H. Moon, and J. K. Sohng. 2003. Identification of 2- deoxy-scyllo-inosose synthase in aminoglycoside producer Streptomyces. J. Microbiol. Biotechnol. 13: 828-831
5 Lapidot, A., V. Vijayabaskar, A. Litovchick, J. Yu, and T. L. James. 2004. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy. FEBS Lett. 577: 415- 421   DOI   ScienceOn
6 Luedtke, N. W., Q. Liu, and Y. Tor. 2003. RNA-ligand interactions: Affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element. Biochemistry 42: 11391-11403   DOI   ScienceOn
7 Olsen, H. S., P. Nelbock, A. W. Cochrane, and C. A. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science 247: 845- 848   DOI
8 Peterson, R. D., D. P. Bartel, J. W. Szostak, S. J. Horvath, and J. Feigon. 1994. $^{1}H$ NMR studies of the high-affinity Rev binding site of the Rev Responsive Element of HIV-1 mRNA: Base pairing in the core binding element. Biochemistry 33: 5357-5366   DOI   ScienceOn
9 Peterson, R. D. and J. Feigon. 1996. Structural change in Rev Responsive Element RNA of HIV-1 on binding Rev peptide. J. Mol. Biol. 264: 863-877   DOI   ScienceOn
10 Tok, J., L. J. Dunn, and R. C. Des Jean. 2001. Binding of dimeric aminoglycosides to the HIV-1 Rev responsive element (RRE) RNA construct. Bioog. Med. Chem. Lett. 11: 1127-1131   DOI   ScienceOn
11 Zhao, X.-Q., K.-R. Kim, L. W. Sang, S.-H. Kang, Y.-Y. Yang, and J.-W. Suh. 2005. Genetic organization of a 50-kb gene cluster isolated from streptomyces kanamyceticus for kanamycin biosynthesis and characterization of kanamycin acetyltransferase. J. Microbiol. Biotechnol. 15: 346-353   과학기술학회마을
12 Zheng, M., H. Huang, G. K. Smith, X. Yang, and X. Gao. 1996. Genetically unstable CXG repeats are structurally dynamic and have a high propensity for folding. An NMR and UV spectroscopic study. J. Mol. Biol. 264: 323-336   DOI   ScienceOn
13 Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet- Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871   DOI
14 Mikkelsen1, N. E., K. Johansson, A. Virtanen, and L. A. Kirsebom. 2001. Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nat. Struct. Biol. 8: 510-514   DOI   ScienceOn
15 Van Ryk, D. I. and S. Venkatesan. 1999. Real-time kinetics of HIV-1 Rev-rev responsive element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis. J. Biol. Chem. 274: 17452-17463   DOI
16 Battiste, J. L., R. Tan, A. D. Frankel, and J. R. Williamson. 1994. Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs. Biochemistry 33: 2741-2747   DOI   ScienceOn
17 Lynch, S. R., R. L. Gonzalez, and J. D. Puglisi. 2003. Comparison of X-ray crystal structure of the 30S subunit-antibiotic complex with NMR structure of decoding site oligonucleotide-paromomycin complex. Structure (Camb.) 11: 43-53   DOI   ScienceOn
18 Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60: 675-683   DOI   ScienceOn
19 Kirk, S. R., N. W. Leudtke, and Y. Tor. 2000. Neomycin-acridine conjugate: A potential inhibitor of Rev-RRE binding. J. Am. Chem. Soc. 122: 980-981   DOI   ScienceOn
20 Milligan, J. F., D. R. Groebe, G. W. Witherell, and O. C. Uhlenbeck. 1987. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15: 8793-8798
21 Hung, L.-W., E. L. Holbrook, and S. R. Holbrook. 2000. The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability. Proc. Natl. Acad. Sci. USA 97: 5107-5112
22 Yoshizawa, S., D. Fourmy, and J. D. Puglisi. 1998. Structural origins of gentamycin antibiotic action. EMBO J. 17: 6437- 6448   DOI   ScienceOn
23 Hendrix, M., S. Priestly, G. F. Joyce, and C. H. Wong. 1997. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance. J. Am. Chem. Soc. 119: 3641- 3648   DOI   ScienceOn
24 Tuerk, C. and S. MacDougal-Waugh. 1993. In vitro evolution of functional nucleic acids: High-affinity RNA ligands of HIV-1 proteins. Gene 137: 33-39   DOI   ScienceOn
25 Battiste, J. L., H. Mao, S. Rao, R. Tan, D. R. Muhandiram, L. E. Kay, A. D. Frankel, and J. R. Williamson. 1996. ${\alpha}$ Helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science 273: 1547-1551   DOI   ScienceOn
26 Zapp, M. L. and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342: 714-716   DOI   ScienceOn
27 Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338: 254-257   DOI   ScienceOn
28 Felber, B. K., M. Hadzopouloucladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86: 1495-1499
29 Greenberg, W. A., E. S. Priestley, P. S. Sears, P. B. Alper, C. Rosenbohm, M. Hendrix, S.-C. Hung, and C.-H. Wong. 1999. Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: Correlation of antibiotic activity with in vitro inhibition of translation. J. Am. Chem. Soc. 121: 6527-6541   DOI   ScienceOn
30 Lacourciere, K. A., J. T. Stivers, and P. Marino. 2000. Mechanism of neomycin and Rev peptide binding to Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy. Biochemistry 39: 5630-5641   DOI   ScienceOn
31 Rhee, K. Y. 2003. Purification and identification of an antifungal agent from Streptomyces sp. KH-614 antagonistic to rice blast fungus Pyricularia oryzae. J. Microbiol. Biotechnol. 13: 984-988
32 Cochrane, A. W., C. H. Chen, and C. A. Rosen. 1990. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA 87: 1198-1202
33 Puglish, J. D. and I. Jr. Tinoco. 1989. Absorbance melting curves of RNA. Methods Enzymol. 180: 304-325   DOI
34 Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122   DOI   ScienceOn
35 Calnan, B. J., B. Tidor, S. Biancalana, D. Hudson, and A. D. Frankel. 1991. Arginine-mediated RNA recognition: The arginine fork. Science 252: 1167-1171   DOI
36 Milligan, J. F. and O. C. Uhlenbeck. 1989. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 180: 51-62   DOI
37 Plateau, P. and M. Gueron. 1982. Exchangeable proton NMR without base-line distortion, using new strong-pulse sequences. J. Am. Chem. Soc. 104: 7301-7311
38 Hamasaki, K. and A. Ueno. 2001. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for RNA-protein interactions derived from HIV-1 activators. Bioorg. Med. Chem. Lett. 11: 591-594   DOI   ScienceOn
39 Turner, B. G. and M. F. Summers. 1998. Structural biology of HIV. J. Mol. Biol. 285: 1-32 and references therein   DOI   ScienceOn
40 Cho, B.-G., C.-H. Kim, B. K. Lee, and S.-H. Cho. 2005. Comparison of antibiotics resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733   과학기술학회마을